Parkman Healthcare Partners’s Alpha Teknova TKNO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-251,026
Closed -$1.21M 100
2024
Q3
$1.21M Sell
251,026
-45,626
-15% -$168K 0.16% 84
2024
Q2
$406K Buy
296,652
+450
+0.2% +$856 0.05% 89
2024
Q1
$785K Buy
296,202
+13,966
+5% +$43.3K 0.1% 94
2023
Q4
$1.05M Buy
282,236
+48,490
+21% +$120K 0.15% 79
2023
Q3
$652K Buy
233,746
+57,432
+33% +$151K 0.12% 98
2023
Q2
$471K Buy
176,314
+25,059
+17% +$67.3K 0.08% 93
2023
Q1
$448K Buy
151,255
+22,797
+18% +$114K 0.1% 79
2022
Q4
$725K Buy
128,458
+7,034
+6% +$31.2K 0.19% 75
2022
Q3
$406K Buy
121,424
+1,427
+1% +$7.98K 0.12% 85
2022
Q2
$1.01M Buy
119,997
+529
+0.4% +$5.58K 0.37% 58
2022
Q1
$1.65M Buy
119,468
+14,260
+14% +$224K 0.48% 54
2021
Q4
$2.15M Buy
105,208
+23,836
+29% +$529K 0.48% 55
2021
Q3
$2.02M Buy
+81,372
New +$1.74M 0.51% 53

Other funds holding TKNO

Parkman Healthcare Partners's TKNO Position: Q4 2024 in Review

Parkman Healthcare Partners sold out of Alpha Teknova (TKNO) in Q4 2024, closing a stake of 251,026 shares — an estimated $1.21M sold.

Parkman Healthcare Partners first reported a position in TKNO in Q3 2021 and held it in 13 quarters. The position peaked at $2.15M in Q4 2021. 47 funds tracked by Wall St. Rank hold TKNO as of Q4 2024.

  • Parkman Healthcare Partners reported no remaining Alpha Teknova position as of Q4 2024 after selling out during the quarter.
  • Parkman Healthcare Partners sold 251,026 Alpha Teknova shares in Q4 2024, an estimated $1.21M.
  • Parkman Healthcare Partners first reported a position in Alpha Teknova in Q3 2021 and held it in 13 quarters.
  • Parkman Healthcare Partners's Alpha Teknova position peaked at $2.15M in Q4 2021.
  • 47 funds tracked by Wall St. Rank held Alpha Teknova as of Q4 2024.

Based on Parkman Healthcare Partners's 13F filing for Q4 2024, filed 14 Feb 2025.